| Financial Year |
September 30 2019 |
| Monetary Funds |
1,001,477,270.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
30,450,000.00 |
| Accounts Receivable |
902,181,398.78 |
| Advances to Suppliers |
106,785,474.84 |
| Other Receivables |
286,755,704.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
68,472,899.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
531,995,397.80 |
| Total Current Assets |
2,928,118,146.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
260,000,000.00 |
| Investment Properties |
14,879,700.00 |
| Fixed Assetes |
8,183,774,818.67 |
| Under-construction Projects |
1,903,903,067.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,435,312.13 |
| R&D expenses |
541,985.61 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
124,966,142.83 |
| Deferred Income Tax Assets |
97,197,633.73 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
10,760,698,660.34 |
| Total Assets |
13,688,816,806.64 |
| Short-Term Loans |
1,265,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
229,272,573.19 |
| Accounts Payable |
1,109,044,014.46 |
| Accounts Received In Advance |
121,506,561.00 |
| Employee Compensation Payable |
4,997,759.34 |
| Taxes Payable |
36,799,698.82 |
| Interest Payable |
51,873,860.67 |
| Dividend Payable |
-- |
| Other payables |
143,900,740.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,650,855.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,920,172,202.56 |
| Long-term Loans |
5,869,313,607.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
566,372,557.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,755,565.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,993,347,156.65 |
| Total Liabilities |
9,913,519,359.21 |
| Paid-In Capital(Or Share Stock) |
1,102,273,226.00 |
| Capital Surplus |
1,183,517,333.71 |
| Surplus Reserve |
86,306,245.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
450,514,036.07 |
| Minority Stockholder's Interest |
952,686,606.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,822,610,841.26 |
| Owner's Equity（Stockholder's Equity） |
3,775,297,447.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,688,816,806.64 |
